Catherine A. Schevon, MD, PhD

Julia Yasek, MS, FNP-BC, DNP is a Clinical Research Nurse Practitioner in the Division of Neuromuscular Medicine. Prior to pursuing nursing, Dr. Yasek conducted laboratory and clinical research in the Department of Neurology at the University of Massachusetts (UMass) Medical School and Massachusetts General Hospital, with a focus on neuromuscular disorders, genetics, and imaging. She subsequently graduated from the UMass Medical School Doctor of Nursing Practice (DNP) Program, and practiced for several years in both an inpatient acute care setting and a primary care practice, with a focus on underserved populations. Dr. Yasek also has interests and training in palliative care, healthcare policy, and quality improvement, and brings these many skills to her role, as part of the multidisciplinary care team in the Eleanor and Lou Gehrig ALS Center.

Gordon Baltuch MD, PhD, FACS, FRCS(C) is the Co-Chief of Functional Neurosurgery Division at Columbia Neurosurgery. Dr. Baltuch specializes in the surgical treatment of movement disorders and was previously director of the Penn Center for Functional and Restorative Neurosurgery and professor of neurosurgery at the University of Pennsylvania Perelman School of Medicine, where he had been a faculty member since 1996. Dr. Baltuch was one of the first neurosurgeons in the United States to use deep brain stimulation to reduce tremor and other motor symptoms in people with Parkinson’s disease and other movement disorders. After training in Montreal, Switzerland, and France, Dr. Baltuch moved to Penn to develop one of the first deep brain stimulation programs in the United States. He has treated more than 1,600 patients using the procedure, making him one of the most experienced neurosurgeons in functional neurosurgery. He also pioneered the use of the technology to treat epilepsy, depression, and Alzheimer’s disease. More recently, Dr. Baltuch also became a pioneer in the use of focused ultrasound, a nonsurgical procedure approved in 2016 to treat essential tremor. Since 2017, he has successfully performed hundreds of these procedures and developed Penn’s focused ultrasound program into one of the largest such practices in the country. Before joining Penn, Dr. Baltuch completed a fellowship in Lausanne, Switzerland, and a residency in neurosurgery at the Montreal Neurological Institute (MNI). He earned his MD and PhD degrees at McGill University. Among other honors, Dr. Baltuch received the Wilder Penfield Award in Neurosurgery from the MNI, the K.G. McKenzie Award for Basic Science Research from the Canadian Neurosurgical Society, and the Luigi Mastroianni Clinical Innovator Award of Excellence from the Faculty of Medicine at Penn. He is a fellow of the American College of Surgeons and Royal College of Surgeons of Canada.

Matthew Harms, MD is an Associate Professor of Neurology. Dr. Harms received his A.B. in Biology summa cum laude from Harvard University in 1997, and his medical doctorate from the University of California San Francisco in 2003. He remained at San Francisco for neurology residency and served as Chief Resident in his final year. Dr. Harms completed neuromuscular medicine and clinical neurophysiology fellowships under the mentorship of Dr. Alan Pestronk at Washington University in St. Louis. His clinical training in neuromuscular diseases led him into the laboratory of Dr. Robert Baloh, where his post-doctoral research identified the genes responsible for two orphan human diseases- dominant spinal muscular atrophy with lower extremity predominance and limb-girdle muscular dystrophy type 1D. Dr. Harms joined the neuromuscular medicine faculty at Washington University in 2009 with board certifications in neurology, clinical neurophysiology, and neuromuscular medicine. In 2011, Dr. Harms assumed leadership of the Washington University Neuromuscular Genetics Project and established his research laboratory to continue harnessing emerging genetic technologies to understand the causes of inherited neuromuscular diseases. The lab focuses on diseases of the motor neuron, including amyotrophic lateral sclerosis, spinal muscular atrophy, and the hereditary motor neuropathies, and where his efforts have helped identify more than 5 novel disease genes. Here at Columbia, he will continue these efforts, directing an international multi-site effort using whole genome and transcriptome sequencing to bring precision medicine to amyotrophic lateral sclerosis. His laboratory efforts will occur in both the Motor Neuron Center and the Institute for Genomic Medicine.